Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthéra))and General Corticotherapy Treatment in Patients With Pemphigus

NCT00784589 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT00784589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00784589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthéra))and General Corticotherapy Treatment in Patients With Pemphigus
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
December 31, 2016
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus disease